• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿科哮喘更新:精选问题。

Update in Pediatric Asthma: Selected Issues.

机构信息

Department of Pediatric and Adolescent Medicine, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, MI, United States.

Department of Pediatric and Adolescent Medicine, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, MI, United States.

出版信息

Dis Mon. 2020 Apr;66(4):100886. doi: 10.1016/j.disamonth.2019.100886. Epub 2019 Sep 27.

DOI:10.1016/j.disamonth.2019.100886
PMID:31570159
Abstract

Asthma is a complex condition that affects 14% of the world's children and the approach to management includes both pharmacologic as well as non-pharmacologic strategies including attention to complex socioeconomic status phenomena. After an historical consideration of asthma, allergic and immunologic aspects of asthma in children and adolescents are presented. Concepts of socioeconomic aspects of asthma are considered along with environmental features and complications of asthma disparities. Also reviewed are links of asthma with mental health disorders, sleep disturbances and other comorbidities. A stepwise approach to asthma management is discussed that includes pharmacologic and non-pharmacologic strategies in the pediatric population. The role of immunotherapy and use of various immunomodulators are considered as well.

摘要

哮喘是一种复杂的疾病,影响着全球 14%的儿童。其管理方法包括药物和非药物策略,包括关注复杂的社会经济地位现象。在对哮喘的历史回顾之后,介绍了儿童和青少年哮喘的过敏和免疫学方面。还考虑了哮喘的社会经济方面的概念,以及环境特征和哮喘差异的并发症。还回顾了哮喘与心理健康障碍、睡眠障碍和其他合并症的关联。讨论了一种针对哮喘管理的逐步方法,包括儿科人群中的药物和非药物策略。还考虑了免疫疗法和各种免疫调节剂的使用。

相似文献

1
Update in Pediatric Asthma: Selected Issues.儿科哮喘更新:精选问题。
Dis Mon. 2020 Apr;66(4):100886. doi: 10.1016/j.disamonth.2019.100886. Epub 2019 Sep 27.
2
Options of immunotherapeutic treatments for children with asthma.哮喘患儿的免疫治疗选择。
Expert Rev Respir Med. 2019 Oct;13(10):937-949. doi: 10.1080/17476348.2019.1656533. Epub 2019 Aug 21.
3
Efficacy and effectiveness of omalizumab in the treatment of childhood asthma.奥马珠单抗治疗儿童哮喘的疗效和有效性。
Expert Rev Respir Med. 2018 Sep;12(9):745-754. doi: 10.1080/17476348.2018.1507740. Epub 2018 Aug 28.
4
Management of asthma during pregnancy.孕期哮喘的管理
Allergy Asthma Proc. 2004 Nov-Dec;25(6):375-9.
5
[Latin-American Consensus on Difficult-to-Control Asthma. 2008 Update].[拉丁美洲难治性哮喘共识。2008年更新]
Drugs Today (Barc). 2008 Jun;44 Suppl 3:1-43.
6
Montelukast: data from clinical trials in the management of asthma.孟鲁司特:哮喘管理临床试验数据。
Ann Pharmacother. 1999 Dec;33(12):1299-314. doi: 10.1345/aph.18430.
7
Concomitant asthma medications in moderate-to-severe allergic asthma treated with omalizumab.奥马珠单抗治疗中重度过敏性哮喘时的伴随哮喘药物。
Respir Med. 2013 Jan;107(1):60-7. doi: 10.1016/j.rmed.2012.09.008. Epub 2012 Oct 18.
8
Omalizumab as add-on therapy to inhaled steroids for asthma.奥马珠单抗作为吸入性糖皮质激素治疗哮喘的附加疗法。
Issues Emerg Health Technol. 2004 Jun(58):1-4.
9
Long-term treatment in pediatric asthma: an update on chemical pharmacotherapy.儿童哮喘的长期治疗:化学药物治疗的最新进展
Expert Opin Pharmacother. 2017 May;18(7):667-676. doi: 10.1080/14656566.2017.1317747. Epub 2017 Apr 20.
10
Prevention of asthma morbidity: recent advances.哮喘发病率的预防:最新进展
Curr Opin Pediatr. 2000 Oct;12(5):438-43. doi: 10.1097/00008480-200010000-00003.

引用本文的文献

1
Systemic IL-26 correlates with improved asthma control in children sensitized to dog allergen.系统性白细胞介素-26 与对狗过敏原过敏的儿童哮喘控制改善相关。
Respir Res. 2024 Apr 15;25(1):163. doi: 10.1186/s12931-024-02773-7.
2
Traditional Chinese Medicine Based Acupoint Application for Asthma Treatment in Children: A Meta-Analysis and Systematic Review.基于中医穴位敷贴治疗儿童哮喘的Meta分析与系统评价
Evid Based Complement Alternat Med. 2022 Sep 26;2022:7500056. doi: 10.1155/2022/7500056. eCollection 2022.
3
The Evolution of Scientific Knowledge in Childhood Asthma over Time: A Surprising History.
儿童哮喘科学知识随时间的演变:一段惊人的历史。
Children (Basel). 2024 Feb 18;11(2):262. doi: 10.3390/children11020262.
4
Long non-coding RNA (LncRNA) non-coding RNA activated by DNA damage (NORAD) knockdown alleviates airway remodeling in asthma via regulating miR-410-3p/RCC2 and inhibiting Wnt/β-catenin pathway.长链非编码RNA(LncRNA)DNA损伤激活的非编码RNA(NORAD)敲低通过调节miR-410-3p/RCC2和抑制Wnt/β-连环蛋白通路减轻哮喘气道重塑。
Heliyon. 2023 Dec 15;10(1):e23860. doi: 10.1016/j.heliyon.2023.e23860. eCollection 2024 Jan 15.
5
Online-merge-offline (OMO)-based music therapy for asthmatic children during the COVID-19 pandemic in China.基于线上线下融合(OMO)的音乐疗法对 COVID-19 大流行期间中国哮喘儿童的作用。
Eur J Pediatr. 2024 Mar;183(3):1277-1286. doi: 10.1007/s00431-023-05361-x. Epub 2023 Dec 16.
6
Music Therapy in Pediatric Asthma: A Short Review.小儿哮喘的音乐疗法:简短综述
J Asthma Allergy. 2023 Oct 4;16:1077-1086. doi: 10.2147/JAA.S414060. eCollection 2023.
7
Current Approaches in the Multimodal Management of Asthma in Adolescents-From Pharmacology to Personalized Therapy.青少年哮喘多模式管理的当前方法——从药理学到个性化治疗
Biomedicines. 2023 Aug 30;11(9):2429. doi: 10.3390/biomedicines11092429.
8
Screening of key genes in childhood asthma based on bioinformatics analysis.基于生物信息学分析的儿童哮喘关键基因筛选
Transl Pediatr. 2023 May 30;12(5):967-976. doi: 10.21037/tp-23-204. Epub 2023 May 22.
9
FOXF1 attenuates TGF‑β1‑induced bronchial epithelial cell injury by inhibiting CDH11‑mediated Wnt/β‑catenin signaling.FOXF1通过抑制CDH11介导的Wnt/β-连环蛋白信号传导减轻转化生长因子-β1诱导的支气管上皮细胞损伤。
Exp Ther Med. 2023 Jan 20;25(3):103. doi: 10.3892/etm.2023.11802. eCollection 2023 Mar.
10
Biologic Therapies in Pediatric Asthma.儿童哮喘的生物疗法
J Pers Med. 2022 Jun 18;12(6):999. doi: 10.3390/jpm12060999.